The China plus one strategy encourages diversification of suppliers due to geopolitical risks, which benefits Indian companies across various sectors. In pharma, both traditional and CDMO segments show opportunities. The industrial sector grows more attractive as interest rates drop and currency stabilizes. The strategy also provides a competitive edge to Indian exporters facing Chinese competition.
US stocks: Nasdaq, S&P end lower in volatile session as tech stocks retreat
Tech stocks pulled down the Nasdaq and S&P 500 due to valuation worries and concerns over AI spending, falling crude prices bolstered airlines and travel
June 24, 2026